Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DUPIXENT
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Early-onset Dupilumab Effects in CRSwNP
- Dupilumab De-escalation in Pediatric Atopic Dermatitis
- The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction
- Dupilumab in the Treatment of Pediatric Alopecia Areata
- A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clin
- Dupilumab Effects Against Aeroallergen Challenge
- Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
- Dupilumab Skin Barrier Function and Lipidomics Study in Atopic Dermatitis in China
- A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) or Chronic Inducible Cold Urticaria (CICU) (LIBERTY-CSU/CINDU CUPIDKids)
- A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD
- Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
- Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
- Dupixent and Narrowband UVB for Atopic Dermatitis
- Ethnic Differences in Mechanisms of Action of Dupilumab
- Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
- Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
- Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
- Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
- Mechanisms of Dupilumab in AERD
- Dupilumab in the Treatment of Keloids
- Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
- NMF-CsA-Dupi Trial
- Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
- Dupilumab for Prevention of Recurrence of CRSwNP After ESS
- An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
- Dupilumab in Severe Chronic Hand Eczema
- Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
- Dupilumab Asthma Sleep Study
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
- Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
- Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
- Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
- Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
- Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
- Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Clinical Study Using Biologics to Improve Multi OIT Outcomes
- Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
- The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
- Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
- Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
- Study of REGN3500 and Dupilumab in Patients With Asthma
- Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
- Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
- Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
- Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
- Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
Clinical trials list
click for details